{"id":"W2154006657","doi":"10.1634/theoncologist.10-9-760","title":"Nimotuzumab: Evidence of Clinical Benefit Without Rash","year":2005,"lang":"en","type":"letter","venue":"The Oncologist","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rash; Nimotuzumab; Dermatology; Pharmacology; Oncology; Intensive care medicine; Internal medicine; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00346344,0.0003779648,0.001630339,0.0001342121,0.000091121,0.00003068893,0.001095699,0.001381085,0.007652018],"category_scores_gemma":[0.001662697,0.0002284113,0.000670132,0.0002660365,0.001762414,0.00005177561,0.0003375774,0.005065183,0.0005096315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004398674,"about_ca_system_score_gemma":0.001029726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003734965,"about_ca_topic_score_gemma":0.0001828887,"domain_scores_codex":[0.9957116,0.0005378022,0.001233602,0.0006296427,0.001251859,0.0006355278],"domain_scores_gemma":[0.993413,0.00356725,0.0006314551,0.001882341,0.0003755588,0.0001304203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00117713,0.0001449796,0.008969498,0.0002950371,0.0002911424,0.0003598841,0.000062608,0.000003611158,0.0006354377,0.00001419549,0.9238102,0.06423627],"study_design_scores_gemma":[0.001441474,0.001700498,0.009269919,0.000779525,0.0003623505,0.000149598,0.00002132099,0.0000495836,0.0002541741,0.0001139052,0.9856309,0.000226775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.02424447,0.002595081,0.00001635327,0.9332659,0.0008557102,0.001685391,0.00002666721,0.000114711,0.03719566],"genre_scores_gemma":[0.02609547,0.005150986,0.0009468084,0.6160696,0.02646409,0.0001203066,0.00008313506,0.0001630919,0.3249066],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.3171964,"threshold_uncertainty_score":0.9999153,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2365291259437567,"score_gpt":0.4906644354273119,"score_spread":0.2541353094835552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}